Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity

Oxaliplatin (OHP) is an antineoplastic compound able to induce peripheral neurotoxicity. Oxidative stress has been suggested to be a key factor in the development of OHP-related peripheral neurotoxicity. Mangafodipir, a contrast agent possessing mitochondrial superoxide dismutase (MnSOD)-mimetic act...

Full description

Bibliographic Details
Main Authors: Annalisa Canta, Alessia Chiorazzi, Eleonora Pozzi, Giulia Fumagalli, Laura Monza, Cristina Meregalli, Valentina A. Carozzi, Virginia Rodriguez-Menendez, Norberto Oggioni, Jacques Näsström, Paola Marmiroli, Guido Cavaletti
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/9/7/594
id doaj-6ea08a32b15b46a1ba40a13deca1175c
record_format Article
spelling doaj-6ea08a32b15b46a1ba40a13deca1175c2020-11-25T03:04:31ZengMDPI AGAntioxidants2076-39212020-07-01959459410.3390/antiox9070594Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral NeurotoxicityAnnalisa Canta0Alessia Chiorazzi1Eleonora Pozzi2Giulia Fumagalli3Laura Monza4Cristina Meregalli5Valentina A. Carozzi6Virginia Rodriguez-Menendez7Norberto Oggioni8Jacques Näsström9Paola Marmiroli10Guido Cavaletti11Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyPledPharma AB, Grev Turegatan 11 C, 114 46 Stockholm, SwedenExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, ItalyOxaliplatin (OHP) is an antineoplastic compound able to induce peripheral neurotoxicity. Oxidative stress has been suggested to be a key factor in the development of OHP-related peripheral neurotoxicity. Mangafodipir, a contrast agent possessing mitochondrial superoxide dismutase (MnSOD)-mimetic activity, has been tested as a cytoprotector in chemotherapy-induced peripheral neurotoxicity (CIPN). Calmangafodipir (PledOx<sup>®</sup>) has even better therapeutic activity. We investigated a BALB/c mouse model of OHP-related CIPN and the effects of the pre-treatment of calmangafodipir (2.5, 5, or 10 mg/kg intravenously) on sensory perception, and we performed a pathological study on skin biopsies to assess intraepidermal nerve fiber (IENF) density. At the end of the treatments, OHP alone or in pre-treatment with calmangafodipir 2.5 and 10 mg/kg, induced mechanical allodynia and cold thermal hyperalgesia, but calmangafodipir 5 mg/kg prevented these effects. Accordingly, OHP alone or in pre-treatment with calmangafodipir 2.5 and 10 mg/kg, induced a significant reduction in IENF density, but calmangafodipir 5 mg/kg prevented this reduction. These results confirm a protective effect of calmangafodipir against OHP-induced small fiber neuropathy. Interestingly, these results are in agreement with previous observations suggesting a U-shaped effect of calmangafodipir, with the 10 mg/kg dose less effective than the lower doses.https://www.mdpi.com/2076-3921/9/7/594calmangafodipiroxaliplatinIENF densitycold hyperalgesiamechanical allodynianeurotoxicity
collection DOAJ
language English
format Article
sources DOAJ
author Annalisa Canta
Alessia Chiorazzi
Eleonora Pozzi
Giulia Fumagalli
Laura Monza
Cristina Meregalli
Valentina A. Carozzi
Virginia Rodriguez-Menendez
Norberto Oggioni
Jacques Näsström
Paola Marmiroli
Guido Cavaletti
spellingShingle Annalisa Canta
Alessia Chiorazzi
Eleonora Pozzi
Giulia Fumagalli
Laura Monza
Cristina Meregalli
Valentina A. Carozzi
Virginia Rodriguez-Menendez
Norberto Oggioni
Jacques Näsström
Paola Marmiroli
Guido Cavaletti
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
Antioxidants
calmangafodipir
oxaliplatin
IENF density
cold hyperalgesia
mechanical allodynia
neurotoxicity
author_facet Annalisa Canta
Alessia Chiorazzi
Eleonora Pozzi
Giulia Fumagalli
Laura Monza
Cristina Meregalli
Valentina A. Carozzi
Virginia Rodriguez-Menendez
Norberto Oggioni
Jacques Näsström
Paola Marmiroli
Guido Cavaletti
author_sort Annalisa Canta
title Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
title_short Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
title_full Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
title_fullStr Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
title_full_unstemmed Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
title_sort calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity
publisher MDPI AG
series Antioxidants
issn 2076-3921
publishDate 2020-07-01
description Oxaliplatin (OHP) is an antineoplastic compound able to induce peripheral neurotoxicity. Oxidative stress has been suggested to be a key factor in the development of OHP-related peripheral neurotoxicity. Mangafodipir, a contrast agent possessing mitochondrial superoxide dismutase (MnSOD)-mimetic activity, has been tested as a cytoprotector in chemotherapy-induced peripheral neurotoxicity (CIPN). Calmangafodipir (PledOx<sup>®</sup>) has even better therapeutic activity. We investigated a BALB/c mouse model of OHP-related CIPN and the effects of the pre-treatment of calmangafodipir (2.5, 5, or 10 mg/kg intravenously) on sensory perception, and we performed a pathological study on skin biopsies to assess intraepidermal nerve fiber (IENF) density. At the end of the treatments, OHP alone or in pre-treatment with calmangafodipir 2.5 and 10 mg/kg, induced mechanical allodynia and cold thermal hyperalgesia, but calmangafodipir 5 mg/kg prevented these effects. Accordingly, OHP alone or in pre-treatment with calmangafodipir 2.5 and 10 mg/kg, induced a significant reduction in IENF density, but calmangafodipir 5 mg/kg prevented this reduction. These results confirm a protective effect of calmangafodipir against OHP-induced small fiber neuropathy. Interestingly, these results are in agreement with previous observations suggesting a U-shaped effect of calmangafodipir, with the 10 mg/kg dose less effective than the lower doses.
topic calmangafodipir
oxaliplatin
IENF density
cold hyperalgesia
mechanical allodynia
neurotoxicity
url https://www.mdpi.com/2076-3921/9/7/594
work_keys_str_mv AT annalisacanta calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT alessiachiorazzi calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT eleonorapozzi calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT giuliafumagalli calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT lauramonza calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT cristinameregalli calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT valentinaacarozzi calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT virginiarodriguezmenendez calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT norbertooggioni calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT jacquesnasstrom calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT paolamarmiroli calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
AT guidocavaletti calmangafodipirreducessensoryalterationsandpreventsintraepidermalnervefiberslossinamousemodelofoxaliplatininducedperipheralneurotoxicity
_version_ 1724681321078325248